Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,738
datasets available to search
ShareScore release 0.9.0
Dataset results
15,738 results for “Stem cells”
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
ClinicalTrials.gov study NCT01445821. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
ClinicalTrials.gov study NCT02869633. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01842308. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cord Blood Stem Cell Transplantation Study (COBLT)
ClinicalTrials.gov study NCT00000603. IPD Sharing: Not stated. Countries: 0. Publications: 11.
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
ClinicalTrials.gov study NCT00141765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant
ClinicalTrials.gov study NCT05274763. IPD Sharing: NO. Countries: 1. Publications: 0.
Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00073918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients
ClinicalTrials.gov study NCT00948090. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06676852. IPD Sharing: YES. Countries: 1. Publications: 0.
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
ClinicalTrials.gov study NCT02162420. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT01076270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT00445692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft
ClinicalTrials.gov study NCT03187756. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Repeated Mesenchymal Stem Cell Injections in ALS
ClinicalTrials.gov study NCT04821479. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
ClinicalTrials.gov study NCT00792142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
ClinicalTrials.gov study NCT00716911. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites
ClinicalTrials.gov study NCT04234750. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
ClinicalTrials.gov study NCT02999854. IPD Sharing: NO. Countries: 13. Publications: 0.
5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00721214. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00808080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.